ag-490 has been researched along with Bone-Neoplasms* in 2 studies
2 other study(ies) available for ag-490 and Bone-Neoplasms
Article | Year |
---|---|
IL-11 is essential in promoting osteolysis in breast cancer bone metastasis via RANKL-independent activation of osteoclastogenesis.
A variety of osteolytic factors have been identified from breast cancer cells leading to osteolysis, but less is known about which factor plays an essential role in the initiation process prior to the overt vicious osteolytic cycle. Here, we present in vitro and in vivo evidences to clarify the role of interleukin-11 (IL-11) as an essential contributor to breast cancer bone metastasis mediated osteolysis. Animal studies showed that bone specific metastatic BoM-1833 cells induce earlier onset of osteolysis and faster tumor growth compared with MCF7 and parental MDA-MB-231 cells in BALB/c-nu/nu nude mice. IL-11 was further screened and identified as the indispensable factor secreted by BoM-1833 cells inducing osteoclastogenesis independently of receptor activator of nuclear factor κB ligand (RANKL). Mechanistic investigation revealed that the JAK1/STAT3 signaling pathway as a downstream effector of IL-11, STAT3 activation further induces the expression of c-Myc, a necessary factor required for osteoclastogenesis. By inhibiting STAT3 phosphorylation, AG-490 was shown effective in reducing osteolysis and tumor growth in the metastatic niche. Overall, our results revealed the essential role and the underlying molecular mechanism of IL-11 in breast cancer bone metastasis mediated osteolysis. STAT3 targeting through AG-490 is a potential therapeutic strategy for mitigating osteolysis and tumor growth of bone metastatic breast cancer. Topics: Animals; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Interleukin-11; Janus Kinase 1; Kaplan-Meier Estimate; Macrophage Colony-Stimulating Factor; Mice; Mice, Inbred BALB C; Mice, Nude; Osteogenesis; Osteolysis; RANK Ligand; Signal Transduction; STAT3 Transcription Factor; Tyrphostins | 2019 |
[Intrathecal injection of AG-490 reduces bone-cancer-induced spinal cord astrocyte reaction and thermal hyperalgesia in a mouse model].
To investigate the role of spinal interleukin-6-Janus kinase 2 (IL-6-JAK2) signaling transduction pathway in regulating astrocytes activation during the maintenance of bone cancer pain (BCP). Methods: NCTC 2472 fibrosarcoma cells were injected into the femur marrow cavity in C3H/HeNCrlVr male mice to establish BCP model and they were replaced by the equal volume of α-MEM in the sham model. The paw withdrawal latency (PWL) was measured after inoculation of tumor cells. The lumbar enlargement of spinal cord (L3-L5) was isolated, and Real-time RT-PCR and Western blot were used to detect the expression of spinal glial fibrillary acidic protein (GFAP) and JAK2 mRNA and protein, respectively. The expression level of spinal GFAP mRNA indirectly reflect astrocytes activation level. Pain behaviors and spinal cord GFAP mRNA and protein expression were observed at the given time points after intrathecal administration of JAK2 antagonist AG-490. Results: The PWL at 10, 14, 21 d after operation in BCP model group were significantly shorter than that in the sham group (P<0.05); the spinal GFAP and JAK2 mRNA and protein levels were higher in the BCP model group in comparison to mice in the sham group (P<0.05); intrathecal injection of JAK2 agonist AG-490 (30 or 90 nmol) significantly alleviated PWL, and downregulated the expression of spinal GFAP mRNA and protein (P<0.05). Conclusion: The IL-6-JAK2 signaling pathway plays an important role in maintaining the BCP by regulating the expression of GFAP in the spinal cord. Intrathecal injection of AG-490 can reduce the BCP, and inhibit the activation of IL-6-JAK2 signaling pathway, which may be one of the mechanisms for spinal astrocyte activation.. 目的:探讨脊髓水平IL-6-酪氨酸激酶-2(Janus kinase 2,JAK2)信号通路调控星形胶质细胞活化的机制及其对骨癌痛的影响。方法:将NCTC 2472纤维肉瘤细胞注入C3H/HeNCrlVr雄性小鼠股骨骨髓腔制作骨癌痛模型,以不含纤维肉瘤细胞的等体积α-MEM培养基行骨髓腔内注射制作假手术模型。采用热缩足反射潜伏期(paw withdrawal latency,PWL)评估疼痛水平。取腰段脊髓组织(L3~L5水平),分别应用Real-time RT-PCR和Western印迹检测脊髓水平星形胶质细胞中纤维酸性蛋白(glial fibrillary acidic protein,GFAP)和JAK2 mRNA与蛋白表达变化。鞘内注射给予JAK2拮抗剂AG-490,观察小鼠痛行为学及脊髓水平GFAP mRNA和蛋白表达的变化。结果:骨癌痛模型组小鼠术后10,14,21 d的PWL均较假手术组显著缩短(P<0.05);骨癌痛模型组的脊髓组织GFAP和JAK2 mRNA和蛋白表达显著增加(P<0.05);鞘内注射30或90 nmol AG-490可以显著缩短骨癌痛模型组小鼠PWL,同时可以抑制脊髓组织GFAP mRNA和蛋白的表达(P<0.05)。结论:脊髓水平IL-6-JAK2信号通路可能在骨癌痛的维持中发挥重要作用;IL-6-JAK2信号转导通路可能通过抑制星形胶质细胞的活化来发挥镇痛作用。. Topics: Animals; Astrocytes; Bone Neoplasms; Hyperalgesia; Injections, Spinal; Male; Mice; Mice, Inbred C3H; Rats, Sprague-Dawley; Spinal Cord; Tyrphostins | 2018 |